Vig Pamela 4
4 · Mirum Pharmaceuticals, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Vig Pamela
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-11-10$17.05/sh+660$11,254→ 21,902 total
Holdings
- 75,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 660 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.